Patent Assignment
Reel/Frame 066839/0679
Security Interest
Recorded: 2024-03-20
Pages: 19
Assignor
VISUS THERAPEUTICS, INC.
Executed: 2024-03-19
Assignee
LSP 6 HOLDING C.V., AS COLLATERAL AGENT
JOHANNES VERMEERPLEIN 9, 1071 DV, AMSTERDAM, NETHERLANDS
Covered Properties
(35)
Use of Peptides for Promoting Wound Healing
Preparations and Methods for Ameliorating or Reducing Presbyopia
Preparations and Methods for Ameliorating or Reducing Presbyopia
Histatin for Corneal Wound Healing and Ocular Surface Disease
Application:
13/788,761 →
Publication:
US 2013/0310326
Histatin for Corneal Wound Healing and Ocular Surface Disease
Application:
13/788,803 →
Publication:
US 2013/0310327
Use of peptides for promoting wound healing
Application:
13/827,384 →
Publication:
US 2013/0288964
Use of Peptides for Promoting Wound Healing
Use of peptides for promoting wound healing
Use of Peptides for Promoting Wound Healing
Application:
14/735,450 →
Publication:
US 2015/0273014
Histatin for Corneal Wound Healing and Ocular Surface Disease
Histatin for Corneal Wound Healing and Ocular Surface Disease
Application:
16/525,367 →
Publication:
US 2019/0343922
Using Parasympathomimetic Drugs Alone or, in Combination with One or More Alpha Agonists in Pseudophakic Patients, to Create Multi-Focality
Application:
17/618,152 →
Publication:
US 2022/0175734
Carbachol-Brimonidine Formulation to Enhance Anti-Presbyopia Effects
Application:
17/618,157 →
Publication:
US 2022/0257593
Compounds and Formulations for Treating Ophthalmic Diseases
Application:
18/043,146 →
Publication:
US 2023/0322672
Histatin for Corneal Wound Healing and Ocular Surface Disease
Application:
18/061,699 →
Publication:
US 2023/0277620
Using Parasympathomimetic Drugs Alone or, in Combination with One or More Alpha Agonists in Pseudophakic Patients, to Create Multi-Focality
Application:
18/184,447 →
Publication:
US 2023/0210821
Degradant Compound in a Medicament
Application:
18/250,921 →
Publication:
US 2023/0390284
Formulations Comprising Carbachol and Brimonidine to Enhance Anti-Presbyopia Effects
Degradant Compound in a Medicament
Application:
18/535,520 →
Publication:
US 2024/0100046
Histatin For Corneal Wound Healing And Ocular Surface Disease
Application:
61/648,845 →
Using Parasympathomimetic Drugs Alone or, in Combination with One or More Alpha Agonists in Pseudophakic Patients, to Create Multi-Focality
Application:
62/859,678 →
Carabachol-Bromonidine Formulation to Enhance Anti-Presbyopia Effects
Application:
62/859,684 →
Carabachol-Bromonidine Formulation to Enhance Anti-Presbyopia Effects
Application:
62/913,793 →
Using Parasympathomimetic Drugs Alone or, in Combination with One or More Alpha Agonists in Pseudophakic Patients, to Create Multi-Focality
Application:
62/913,794 →
Using Parasympathomimetic Drugs Alone or, in Combination with One or More Alpha Agonists in Pseudophakic Patients, to Create Multi-Focality
Application:
62/963,891 →
Carabachol-Bromonidine Formulation to Enhance Antipresbyopia Effects
Application:
62/963,932 →
Using Parasympathomimetic Drugs Alone or, in Combination with One or More Alpha Agonists in Pseudophakic Patients, to Create Multi-Focality
Application:
62/970,155 →
Carabachol-Bromonidine Formulation to Enhance Antipresbyopia Effects
Application:
62/970,157 →
Degradant Compound in a Medicament
Application:
63/162,367 →
Histatin Combinations and Methods for Inhibiting Cell Loss
Application:
63/224,982 →
Histatin Combinations and Methods for Inhibiting Cell Loss
Application:
63/238,061 →
Histatin Combinations and Methods for Treating or Inhibiting Cell Loss
Application:
63/252,468 →
Degradant Compound in a Medicament
Application:
63/257,024 →
Carbachol Formulations to Enhance Anti-Presbyopia Effects
Application:
63/278,081 →
Synthesis of 2-(Carbamoyloxy)-N,N,N-Trimethylethan-1-Aminium Salts
Application:
63/508,601 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 5, 2013
From: KAUFMAN, HERBERT F.
To: HEK DEVELOPMENT, LLC
Reel/Frame 029753/0980 →
Assignment of Assignor's Interest
Feb 5, 2013
From: KAUFMAN, HERBERT F.
To: HEK DEVELOPMENT, LLC
Reel/Frame 029753/0804 →
Security Interest
Oct 10, 2014
From: RAPID PATHOGEN SCREENING, INC.
To: ROS ACQUISITION OFFSHORE LP
Reel/Frame 033929/0786 →
Assignment of Assignor's Interest
Nov 10, 2014
From: VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS, WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG
To: RAPID PATHOGEN SCREENING, INC.
Reel/Frame 034132/0300 →
Assignment of Assignor's Interest
Jun 11, 2015
From: VEERMAN, ENGELMUNDUS CORNELIS IGNATIUS; VAN NIEUW AMERONGEN, ARIE; BOLSCHER, JOHANNES GERHARDUS MARIA; VAN'T HOF, WILLEM
To: VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS, WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG
Reel/Frame 035890/0455 →
Assignment of Assignor's Interest
Jun 11, 2015
From: VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS, WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG
To: RAPID PATHOGEN SCREENING, INC.
Reel/Frame 035824/0203 →
Assignment of Assignor's Interest
Jun 14, 2016
From: SAMBURSKY, ROBERT P.; VANDINE, ROBERT W.; CONDON, PETER
To: RAPID PATHOGEN SCREENING, INC.
Reel/Frame 038903/0037 →
Security Interest
Dec 20, 2018
From: RAPID PATHOGEN SCREENING, INC.; RPS DIAGNOSTICS, INC.
To: LUMOS DIAGNOSTICS HOLDINGS PTY LTD
Reel/Frame 047834/0030 →
Release of Security Interest
Dec 20, 2018
From: ROS ACQUISITION OFFSHORE LP
To: RAPID PATHOGEN SCREENING, INC.
Reel/Frame 047834/0367 →
Assignment of Assignor's Interest
Jan 31, 2020
From: SAMBURSKY, ROBERT P.; VANDINE, ROBERT W.; CONDON, PETER
To: RAPID PATHOGEN SCREENING, INC.
Reel/Frame 051679/0136 →
Assignment of Assignor's Interest
May 22, 2020
From: HEK DEVELOPMENT, LLC.
To: VISUS THERAPEUTICS, INC.
Reel/Frame 052733/0128 →
Assignment of Assignor's Interest
May 22, 2020
From: RAPID PATHOGEN SCREENING, INC.
To: VISUS THERAPEUTICS, INC.
Reel/Frame 052732/0296 →
Assignment of Assignor's Interest
May 22, 2020
From: HEK DEVELOPMENT, LLC
To: VISUS THERAPEUTICS, INC.
Reel/Frame 052733/0106 →
Assignment of Assignor's Interest
Jun 12, 2020
From: SAMBURSKY, ROBERT P; KAUFMAN, HERBERT E
To: RAPID PATHOGEN SCREENING, INC.
Reel/Frame 052933/0248 →
Assignment of Assignor's Interest
Jul 2, 2020
From: RAPID PATHOGEN SCREENING, INC.
To: VISUS THERAPEUTICS, INC.
Reel/Frame 053107/0732 →
Assignment of Assignor's Interest
Jan 22, 2021
From: SAMBURSKY, ROBERT P
To: RAPID PATHOGEN SCREENING, INC.
Reel/Frame 055002/0367 →
Assignment of Assignor's Interest
Jan 22, 2021
From: KAUFMAN, HERBERT E
To: RAPID PATHOGEN SCREENING, INC.
Reel/Frame 055002/0169 →
Assignment of Assignor's Interest
Jan 22, 2021
From: RAPID PATHOGEN SCREENING, INC.
To: VISUS THERAPEUTICS, INC.
Reel/Frame 055002/0555 →
Corrective Assignment to Correct the the Correct Name of the Inventor Is Herbert E. Kaufman Previously Recorded at Reel: 029753 Frame: 0804. Assignor(S) Hereby Confirms the Assignment.
Dec 29, 2021
From: KAUFMAN, HERBERT E.
To: HEK DEVELOPMENT, LLC
Reel/Frame 058570/0267 →
Assignment of Assignor's Interest
Jul 26, 2023
From: RAPID PATHOGEN SCREENING, INC.
To: VISUS THERAPEUTICS, INC.
Reel/Frame 064395/0392 →
Assignment of Assignor's Interest
Jul 26, 2023
From: SAMBURSKY, ROBERT P.; VANDINE, ROBERT W.; CONDON, PETER
To: RAPID PATHOGEN SCREENING, INC.
Reel/Frame 064395/0362 →
Assignment of Assignor's Interest
Sep 7, 2023
From: PHARMASSIST CMC CONSULTING, LLC
To: VISUS THERAPEUTICS, INC.
Reel/Frame 064824/0091 →
Assignment of Assignor's Interest
Sep 7, 2023
From: SCHIFFMAN, RHETT MEAD
To: VISUS THERAPEUTICS, INC.
Reel/Frame 064823/0892 →
Assignment of Assignor's Interest
Sep 7, 2023
From: FIRESTONE, BRUCE ALAN
To: PHARMASSIST CMC CONSULTING, LLC
Reel/Frame 064823/0933 →
Assignment of Assignor's Interest
Nov 19, 2024
From: VIEWPOINT THERAPEUTICS, INC.
To: VISUS THERAPEUTICS, INC.
Reel/Frame 069320/0212 →